Nanjing Vishee Medical Technology Co Ltd
SSE:688580

Watchlist Manager
Nanjing Vishee Medical Technology Co Ltd Logo
Nanjing Vishee Medical Technology Co Ltd
SSE:688580
Watchlist
Price: 29.68 CNY 2.52% Market Closed
Market Cap: 2.8B CNY
Have any thoughts about
Nanjing Vishee Medical Technology Co Ltd?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

18.2
Current
23.7
Median
12.6
Industry
Lower than median
Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
18.2
=
Enterprise Value
1.8B CNY
/
EBITDA
99.6m CNY
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
11
2-Years Forward
EV/EBITDA
8.6
3-Years Forward
EV/EBITDA
7

See Also

Discover More